CONSIDERATIONS TO KNOW ABOUT AZELAPRAG FDA APPROVAL

In December, BioAge introduced a multi-12 months exploration collaboration with Novartis to identify and validate novel therapeutic targets in the intersection of aging biology and exercise, combining BioAge's longitudinal human aging datasets with Novartis expertise in exercise biology.To complicate this even more, tirzepatide by itself could have